Lincoln Pharmaceuticals Limited (NSE:LINCOLN) Directors Insider Transactions
The Directors and Chief Executives of Lincoln Pharmaceuticals Limited (NSE:LINCOLN) are required by law to report any insider transaction activities i.e. buying, selling, option exercising the Lincoln Pharmaceuticals Limited's shares in the stock market. Below table shows the list of insider transactions as reported by Lincoln Pharmaceuticals Limited to the NSE stock exchange.
An insider trade occurs when an individual (such as a CEO, CFO or COO) that has non-public information about a company buys or sells shares of that company's stock. Tracking a company's insider trades is a metric that can be used to identify the direction that the company's executives believes that the company is headed. For example, if a number of insiders purchase more shares of a company, they may believe that the company will have strong future earnings and that the share price will increase in the near future.
Lincoln Pharmaceuticals Limited Directors/Insider Transactions Activity
List of Insider trades activity from Lincoln Pharmaceuticals Limited (LINCOLN).
| Date | Director | Director's Title | Shares | Value | Note |
|---|---|---|---|---|---|
| 04 Jun 2024 | Patel (Munjal M) | Promoter | 13,500 | 87,521 | Acquisition at price 6.48 per share. |
| 03 Jun 2024 | Patel (Munjal M) | Wholetime Director | 20,000 | 136,790 | Acquisition at price 6.84 per share. |
| 31 May 2024 | Patel (Munjal M) | Wholetime Director | 15,000 | 101,517 | Acquisition at price 6.77 per share. |
| 27 Feb 2024 | Patel (Nishitkumar Maheshbhai) | Promoter | 1,000 | 8,850 | Sale at price 8.85 per share. |
| 26 Feb 2024 | Patel (Nishitkumar Maheshbhai) | Promoter | 1,000 | 9,066 | Sale at price 9.07 per share. |
| 26 Feb 2024 | Patel (Renukaben M) | Promoter | 1,500 | 13,530 | Sale at price 9.02 per share. |